Based on our results, since 2004, hematological complications such as leukopenia, anemia and thrombocytopenia increased significantly in the APA positive and APA negative patient groups, but not in the APS group; therefore, these are thought to be manifestations of lupus rather than the consequences of APS. This evidence concerns the gene ENPEP and systemic lupus erythematosus.